These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27525312)

  • 1. Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis.
    Cinar R; Iyer MR; Liu Z; Cao Z; Jourdan T; Erdelyi K; Godlewski G; Szanda G; Liu J; Park JK; Mukhopadhyay B; Rosenberg AZ; Liow JS; Lorenz RG; Pacher P; Innis RB; Kunos G
    JCI Insight; 2016 Jul; 1(11):. PubMed ID: 27525312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral Hybrid CB
    Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R
    Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.
    Cinar R; Gochuico BR; Iyer MR; Jourdan T; Yokoyama T; Park JK; Coffey NJ; Pri-Chen H; Szanda G; Liu Z; Mackie K; Gahl WA; Kunos G
    JCI Insight; 2017 Apr; 2(8):. PubMed ID: 28422760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB
    Iyer MR; Cinar R; Katz A; Gao M; Erdelyi K; Jourdan T; Coffey NJ; Pacher P; Kunos G
    J Med Chem; 2017 Feb; 60(3):1126-1141. PubMed ID: 28085283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of second and third generation CB
    Cinar R; Iyer MR; Kunos G
    Pharmacol Ther; 2020 Apr; 208():107477. PubMed ID: 31926199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
    Santos-Molina L; Herrerias A; Zawatsky CN; Gunduz-Cinar O; Cinar R; Iyer MR; Wood CM; Lin Y; Gao B; Kunos G; Godlewski G
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms.
    Roger C; Buch C; Muller T; Leemput J; Demizieux L; Passilly-Degrace P; Cinar R; Iyer MR; Kunos G; Vergès B; Degrace P; Jourdan T
    Diabetes; 2020 Oct; 69(10):2120-2132. PubMed ID: 32680936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual inhibition of cannabinoid CB
    Udi S; Hinden L; Ahmad M; Drori A; Iyer MR; Cinar R; Herman-Edelstein M; Tam J
    Br J Pharmacol; 2020 Jan; 177(1):110-127. PubMed ID: 31454063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: a PET study.
    Takano A; Gulyás B; Varnäs K; Little PB; Noerregaard PK; Jensen NO; Elling CE; Halldin C
    Synapse; 2014 Mar; 68(3):89-97. PubMed ID: 24293119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells.
    Dong Z; Su L; Esmaili S; Iseli TJ; Ramezani-Moghadam M; Hu L; Xu A; George J; Wang J
    J Mol Med (Berl); 2015 Dec; 93(12):1327-39. PubMed ID: 26153548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of
    Iyer MR; Cinar R; Coffey NJ; Kunos G
    J Labelled Comp Radiopharm; 2018 May; ():. PubMed ID: 29790591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase expression (iNOS) in chronic viral hepatitis and its correlation with liver fibrosis.
    Tache DE; Stănciulescu CE; Baniţă IM; Purcaru ŞO; Andrei AM; Comănescu V; Pisoschi CG
    Rom J Morphol Embryol; 2014; 55(2 Suppl):539-43. PubMed ID: 25178323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo.
    Varga B; Kassai F; Szabó G; Kovács P; Fischer J; Gyertyán I
    Pharmacol Biochem Behav; 2017 Aug; 159():24-35. PubMed ID: 28666894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms.
    Mukhopadhyay B; Schuebel K; Mukhopadhyay P; Cinar R; Godlewski G; Xiong K; Mackie K; Lizak M; Yuan Q; Goldman D; Kunos G
    Hepatology; 2015 May; 61(5):1615-26. PubMed ID: 25580584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of inducible nitric oxide (NO) synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury.
    Tipoe GL; Leung TM; Liong E; So H; Leung KM; Lau TY; Tom WM; Fung ML; Fan ST; Nanji AA
    Histol Histopathol; 2006 Nov; 21(11):1157-65. PubMed ID: 16874658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet.
    Chen Y; Hozawa S; Sawamura S; Sato S; Fukuyama N; Tsuji C; Mine T; Okada Y; Tanino R; Ogushi Y; Nakazawa H
    Biochem Biophys Res Commun; 2005 Jan; 326(1):45-51. PubMed ID: 15567150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Therapeutic Mechanisms of Propolis Against CCl
    Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
    Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral cannabinoid 1 receptor blockade mitigates adipose tissue inflammation via NLRP3 inflammasome in mouse models of obesity.
    Han JH; Shin H; Rho JG; Kim JE; Son DH; Yoon J; Lee YJ; Park JH; Song BJ; Choi CS; Yoon SG; Kim IY; Lee EK; Seong JK; Kim KW; Kim W
    Diabetes Obes Metab; 2018 Sep; 20(9):2179-2189. PubMed ID: 29740969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.